Chemomab Therapeutics Ltd.
CMMB
Revenue
0.00
0.000.00%
-Assets
12.57M
▲10.49M▲502.49%
12 Months ChangeLiabilities
13.66M
▲10.97M▲406.82%
12 Months ChangeFree Cash Flow
-7.19M
▼-3.46M▼-92.94%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-03-28
Form 20-F
ID: 0001178913-24-001124
2023-06-16
Form 8-K
ID: 0001178913-23-002225
2023-06-05
Form 8-K
ID: 0001178913-23-002136
2023-05-11
Form 8-K
ID: 0001178913-23-001809
2023-05-11
Form 10-Q
ID: 0001178913-23-001807
2023-02-21
Form 8-K
ID: 0001178913-23-000679
2023-02-21
Form 8-K
ID: 0001178913-23-000670
2023-01-11
Form 8-K
ID: 0001178913-23-000147
2023-01-03
Form 8-K
ID: 0001178913-23-000010
2022-11-16
Form 8-K
ID: 0001178913-22-004061